- Report
- March 2024
- 186 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- November 2023
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- November 2023
- 150 Pages
Global
From €4663EUR$4,850USD£4,001GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2885EUR$3,000USD£2,475GBP
- Report
- May 2024
- 93 Pages
Global
From €5385EUR$5,600USD£4,619GBP
- Report
- May 2024
- 94 Pages
Global
From €5385EUR$5,600USD£4,619GBP
- Report
- January 2024
- 285 Pages
Global
From €9135EUR$9,500USD£7,836GBP
- Report
- January 2024
- 142 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- October 2023
- 178 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- February 2024
- 115 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- January 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- March 2024
- 195 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 185 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 189 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- May 2024
- 898 Pages
Global
From €5385EUR$5,600USD£4,619GBP
- Report
- March 2024
- 30 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Report
- March 2024
- 30 Pages
Global
From €3125EUR$3,250USD£2,681GBP
- Report
- March 2024
- 30 Pages
Global
From €3125EUR$3,250USD£2,681GBP
The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more